“…Several reports (Arts et al, 2003;Plitnick et al, 2003;Vanoirbeek et al, 2003;Ban et al, 2006;Fukuyama et al, 2008aFukuyama et al, and 2008bFukuyama et al, , 2009Fukuyama et al, , 2010a have shown that dermal TMA exposure increases a T H 2 cytokine secretion pattern in mice. In contrast, identical dermal exposure to DNCB, which causes delayed-type hypersensitivity reactions but lacks the potential to cause respiratory hypersensitivity, elicits the T H 1-type cytokine secretion profile (Larsen et al, 2001;Dearman et al, 2005;Matheson et al, 2005a and2005b;Vanoirbeek et al, 2006;Fukuyama et al, 2008aFukuyama et al, and 2008bFukuyama et al, , 2009Fukuyama et al, , 2010a. These low-molecular weight chemicals are well-known human allergens (Larsen et al, 2001;Matheson et al, 2005a and2005b) that have been used extensively in experimental research on chemical hypersensitivity.…”